Paper36285486
Nsp16 shields SARS-CoV-2 from efficient MDA5 sensing and IFIT1-mediated restriction.
Russ A and 8 others. EMBO Rep, 2022. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Nsp16 shields SARS-CoV-2 from efficient MDA5 sensing and IFIT1-mediated restriction. Papers, record 36285486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36285486
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| SARS-CoV-2 | Major topic |
| COVID-19 | Major topic |
| Humans | |
| RNA | |
| Methyltransferases | |
| RNA-Binding Proteins | |
| Adaptor Proteins, Signal Transducing |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24098121 | Sequestration by IFIT1 impairs translation of 2'O-unmethylated capped RNA. | PLoS Pathog | 2013 | https://conductscience.org/library/papers/24098121 | PubMed |
| 2 | 32709887 | Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin. | Nat Commun | 2020 | https://conductscience.org/library/papers/32709887 | PubMed |
| 3 | 21217758 | Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. | Nat Immunol | 2011 | https://conductscience.org/library/papers/21217758 | PubMed |
| 4 | 24478444 | Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity. | J Virol | 2014 | https://conductscience.org/library/papers/24478444 | PubMed |
| 5 | 26187414 | A Conserved Histidine in the RNA Sensor RIG-I Controls Immune Tolerance to N1-2'O-Methylated Self RNA. | Immunity | 2015 | https://conductscience.org/library/papers/26187414 | PubMed |
| 6 | 24909568 | IFIT1: A dual sensor and effector molecule that detects non-2'-O methylated viral RNA and inhibits its translation. | Cytokine Growth Factor Rev | 2014 | https://conductscience.org/library/papers/24909568 | PubMed |
| 7 | 27317694 | mRNA capping: biological functions and applications. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/27317694 | PubMed |
| 8 | 35833542 | Attenuation of SARS-CoV-2 replication and associated inflammation by concomitant targeting of viral and host cap 2'-O-ribose methyltransferases. | EMBO J | 2022 | https://conductscience.org/library/papers/35833542 | PubMed |
| 9 | 34786565 | All hands on deck: SARS-CoV-2 proteins that block early anti-viral interferon responses. | Curr Res Virol Sci | 2021 | https://conductscience.org/library/papers/34786565 | PubMed |
| 10 | 17038590 | 5'-Triphosphate RNA is the ligand for RIG-I. | Science | 2006 | https://conductscience.org/library/papers/17038590 | PubMed |
| 11 | 27096317 | Recognition of Endogenous Nucleic Acids by the Innate Immune System. | Immunity | 2016 | https://conductscience.org/library/papers/27096317 | PubMed |
| 12 | 21956912 | Enzymology of RNA cap synthesis. | Wiley Interdiscip Rev RNA | 2010 | https://conductscience.org/library/papers/21956912 | PubMed |
| 13 | 34078893 | A metal ion orients SARS-CoV-2 mRNA to ensure accurate 2'-O methylation of its first nucleotide. | Nat Commun | 2021 | https://conductscience.org/library/papers/34078893 | PubMed |
| 14 | 33976430 | RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells. | Nat Immunol | 2021 | https://conductscience.org/library/papers/33976430 | PubMed |
| 15 | 32330414 | The Architecture of SARS-CoV-2 Transcriptome. | Cell | 2020 | https://conductscience.org/library/papers/32330414 | PubMed |
| 16 | 18591409 | Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. | J Exp Med | 2008 | https://conductscience.org/library/papers/18591409 | PubMed |
| 17 | 34101213 | SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation. | EMBO J | 2021 | https://conductscience.org/library/papers/34101213 | PubMed |
| 18 | 21085181 | 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. | Nature | 2010 | https://conductscience.org/library/papers/21085181 | PubMed |
| 19 | 34355795 | A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model. | Eur J Immunol | 2022 | https://conductscience.org/library/papers/34355795 | PubMed |
| 20 | 33514628 | SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells. | J Virol | 2021 | https://conductscience.org/library/papers/33514628 | PubMed |
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42160380 | Redundant and distinct mechanisms suppress innate immune activation during SARS-CoV-2 infection. | PLoS Biol | 2026 | https://conductscience.org/library/papers/42160380 | PubMed |
| 42037394 | Synergistic antiviral effects of structure-guided peptides and a mutagenic base analog on SARS-CoV-2 replication. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/42037394 | PubMed |
| 42018583 | Live attenuated vaccination protects aged chimeric ACE2 mice from severe SARS-CoV-2 pathogenicity in vivo. | PLoS Pathog | 2026 | https://conductscience.org/library/papers/42018583 | PubMed |
| 41871251 | Inhibition of coronaviral exoribonuclease activity by TRIM-mediated SUMOylation. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/41871251 | PubMed |
| 41789918 | The EP424R protein of African swine fever virus functions as a 2'-O-methyltransferase and plays an important role in viral replication. | mBio | 2026 | https://conductscience.org/library/papers/41789918 | PubMed |
| 41568342 | S‑Adenosylhomocysteine Analogs Selectively Suppress Pan-Coronavirus Replication by Inhibition of nsp14 Methyltransferase. | ACS Med Chem Lett | 2026 | https://conductscience.org/library/papers/41568342 | PubMed |
| 41472136 | A Comprehensive View on the Mechanisms of Coronavirus Escaping Innate Immunity. | Vet Sci | 2025 | https://conductscience.org/library/papers/41472136 | PubMed |
| 41390777 | Adenoviral vector oropharyngeal spray immunization elicits mucosal immunity and protects against heterologous SARS-CoV-2 infection. | NPJ Vaccines | 2025 | https://conductscience.org/library/papers/41390777 | PubMed |
| 41080534 | Mechanism by which porcine transmissible gastroenteritis virus disrupts host innate immunity. | Front Immunol | 2025 | https://conductscience.org/library/papers/41080534 | PubMed |
| 41004586 | Development of SARS-CoV-2 as a viral vector: A novel intranasal bivalent vaccine for SARS-CoV-2 and RSV. | Sci Adv | 2025 | https://conductscience.org/library/papers/41004586 | PubMed |
| 40875735 | Identification of potent antibacterial inhibitors targeting methyltransferase Mtr1/TrmD in Haemophilus influenzae via molecular dynamics simulations. | PLoS One | 2025 | https://conductscience.org/library/papers/40875735 | PubMed |
| 40686860 | Antisense oligonucleotides targeting the SARS-CoV-2 nucleocapsid gene decrease viral titers in hamsters. | Mol Ther Nucleic Acids | 2025 | https://conductscience.org/library/papers/40686860 | PubMed |
| 40358464 | SARS-CoV-2 nsp16 is regulated by host E3 ubiquitin ligases, UBR5 and MARCHF7. | Elife | 2025 | https://conductscience.org/library/papers/40358464 | PubMed |
| 40285011 | Impact of SARS-CoV-2 Wuhan and Omicron Variant Proteins on Type I Interferon Response. | Viruses | 2025 | https://conductscience.org/library/papers/40285011 | PubMed |
| 40220753 | Structural insights into the assembly and regulation of 2'-O RNA methylation by SARS-CoV-2 nsp16/nsp10. | Structure | 2025 | https://conductscience.org/library/papers/40220753 | PubMed |
| 40203104 | Effective recognition of double-stranded RNA does not require activation of cellular inflammation. | Sci Adv | 2025 | https://conductscience.org/library/papers/40203104 | PubMed |
| 40132472 | A live attenuated SARS-CoV-2 vaccine constructed by dual inactivation of NSP16 and ORF3a. | EBioMedicine | 2025 | https://conductscience.org/library/papers/40132472 | PubMed |
| 39836705 | Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion. | PLoS Biol | 2025 | https://conductscience.org/library/papers/39836705 | PubMed |
| 39643445 | An MST-based assay reveals new binding preferences of IFIT1 for canonically and noncanonically capped RNAs. | RNA | 2025 | https://conductscience.org/library/papers/39643445 | PubMed |
| 39478665 | Perspective for Drug Discovery Targeting SARS Coronavirus Methyltransferases: Function, Structure and Inhibition. | J Med Chem | 2024 | https://conductscience.org/library/papers/39478665 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| PDB | 6W4H |
Source PDB
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36285486
GET https://conductscience.org/api/papers/v1/36285486/references?page=2